Clinical and Immunological Outcomes of Rituximab Therapy in Pemphigus: A Prospective Observational Study

Dermatology · Published 2025-12-24 · DOI 10.1159/000550170

Authors being retrieved — see the publisher record. https://doi.org/10.1159/000550170

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Management of All Patients with Multiple Actinic Keratoses Requires Lifelong Follow-Up and Repeated Treatment Cycles: A 12-Year Prospective Observational Study of a Cohort of 81 Patients · Dermatology · 2025 · Same journal
Line-Field Confocal Optical Coherence Tomography Criteria of Hair Follicles in Patients with Hidradenitis Suppurativa versus Healthy Controls · Dermatology · 2026 · Same journal
Patient Perspectives on Treatment Outcomes and Priorities in Autoimmune Bullous Diseases: An Exploratory Survey among Dutch Patients · Dermatology · 2026 · Same journal
Clinical Phenotype Transition in Pemphigus May Suggest Undertreatment with Rituximab: Findings from a Retrospective Single-Centre Analysis of Relapsed Patients · Dermatology · 2026 · Same journal
Mpox Outbreaks Beyond Historically Endemic Regions: A Clinical Review of Vaccination Strategies and Public Health Challenges · Dermatology · 2026 · Same journal
Efficacy of Gabapentin Combined with Standard-Dose Antihistamines versus Antihistamine Monotherapy in Prurigo Nodularis: A Prospective Monocentric Real-World Observational Study · Dermatology · 2026 · Same journal
Smoking Prevalence and Cessation in Skin Cancer Survivors · Dermatology · 2026 · Same journal
Global Pain Management Trends and Barriers to Care in Hidradenitis Suppurativa · Dermatology · 2026 · Same journal
Practitioner-Reported Complications in Tattoo Removal · Dermatology · 2026 · Same journal
Survey on Difficult to Treat Tinea: A Sub-Saharan Africa Snapshot · Dermatology · 2026 · Same journal